Patients with ocular anterior segment dysgenesis (ASD) have a greatly elevated risk of developing severe, early onset glaucoma that is refractory to treatment. Between 50-75% of patients with ASD develop glaucoma, which occurs at significantly younger ages than in the general population, leading to disproportionately diminished quality of life for patients and their families. We propose that intrinsic vascular defects are a primary insult contributing to ASD that are distinct from defects in periocular mesenchyme differentiation. We will test this hypothesis using highly advanced ultramicroscopy, innovative cell-labeling approaches, state-of-the-art nanofluidics technologies and unique and complementary genetic resources. This etiological distinction between migration and differentiation may have significant implications for patient stratification with respect to prognosis, management of modifiable risk factors and awareness of potentially life-threatening co-morbidities ? all of which are important for genetic counseling, family planning and patients' psychological well being.

Public Health Relevance

Individuals with developmental abnormalities of structures in the front of the eye are at high risk to suffer from early onset glaucoma that is refractory to treatment. We will test a novel hypothesis that perturbations in important cell signaling pathways can independently impair migration and differentiation of small populations of critically important cells. Understanding these signaling pathways may be informative for disease prognosis, and awareness of potentially life-threatening comorbidities.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY019887-07
Application #
9716614
Study Section
Biology of the Visual System Study Section (BVS)
Program Officer
Liberman, Ellen S
Project Start
2010-09-30
Project End
2023-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
7
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Protas, Meredith E; Weh, Eric; Footz, Tim et al. (2017) Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma. Hum Mol Genet 26:3630-3638
Mao, Mao; Kiss, Márton; Ou, Yvonne et al. (2017) Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse. Dis Model Mech 10:475-485
Kuo, Debbie S; Sokol, Jared T; Minogue, Peter J et al. (2017) Characterization of a variant of gap junction protein ?8 identified in a family with hereditary cataract. PLoS One 12:e0183438
Mao, Mao; Smith, Richard S; Alavi, Marcel V et al. (2015) Strain-Dependent Anterior Segment Dysgenesis and Progression to Glaucoma in Col4a1 Mutant Mice. Invest Ophthalmol Vis Sci 56:6823-31
Kuo, Debbie S; Labelle-Dumais, Cassandre; Mao, Mao et al. (2014) Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations. Hum Mol Genet 23:1709-22
Jeanne, Marion; Labelle-Dumais, Cassandre; Jorgensen, Jeff et al. (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 90:91-101
Kuo, Debbie S; Labelle-Dumais, Cassandre; Gould, Douglas B (2012) COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21:R97-110
Bai, Xiaoyang; Dilworth, David J; Weng, Yi-Chinn et al. (2009) Developmental distribution of collagen IV isoforms and relevance to ocular diseases. Matrix Biol 28:194-201